L(-)-Carnitine

CAS No. 541-15-1

L(-)-Carnitine( (–)-Carnitine | Levocarnitine )

Catalog No. M14933 CAS No. 541-15-1

L-carnitine is constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 41 In Stock
1G 43 In Stock

Biological Information

  • Product Name
    L(-)-Carnitine
  • Note
    Research use only, not for human use.
  • Brief Description
    L-carnitine is constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.
  • Description
    L-carnitine is constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (–)-Carnitine | Levocarnitine
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Fatty Acid Synthase
  • Recptor
    FAS
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    541-15-1
  • Formula Weight
    161.2
  • Molecular Formula
    C7H15NO3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 32 mg/mL (198.51 mM); Water: 32 mg/mL (198.51 mM); DMSO: 12 mg/mL (74.44 mM)
  • SMILES
    C[N+](C)(CC(O)CC([O-])=O)C
  • Chemical Name
    3-hydroxy-4-(trimethylammonio)butanoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jogl G, Tong L. Cell. 2003 Jan 10; 112(1):113-22.
molnova catalog
related products
  • FASN-IN-2

    FASN-IN-2 is a Fatty Acid Synthase (FASN) inhibitor(IC50 of 0.052 μM and an EC50 of 0.072 μM),with potential antineoplastic activity.?TVB-2640 is an orally bioavailable fatty acid synthase (FASN) inhibitor, with potential antineoplastic activity.

  • Pyrazinamide

    Pyrazinamide (Pyrazinoic acid amide) is an agent used to treat tuberculosis. M. tuberculosis has the enzyme pyrazinamidase which is only active in acidic conditions.

  • FT113

    FT113 is a novel potent inhibitor of fatty acid synthase (fasn IC50 : 213 nM)and exhibits anti-cancer activity.